{"id":1446,"createDateTime":"2026-11-17T03:14:10.591Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Balancing repletion, tolerability and patient fit ","image":"069c365b1d1c703cb0067d18ad632660f3c10a98b7e4877dc022418d","imageThumbnail":"c6f7e04d9fad4e4fc5f49167a567b311a71ea527eb084db09d66beb1","about":"Similar doses of elemental iron can produce markedly different ferritin responses depending on the formulation. GP Dr Sneha explains how to choose an oral iron that replenishes your patient's iron stores and is well tolerated, how timing and dosing affect absorption, and why it's worth checking ferritin at follow-up. \n\nThis activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours. \n\n# Learning Outcomes\n1. Outline how elemental iron dose, formulation and absorption affect oral iron choice and tolerability.\n2. Critically reflect on recent patient interactions to optimise iron replacement based on individual factors.\n3. Apply guideline-aligned oral iron management, confirming repletion with ferritin and haemoglobin.\n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.","type":"video","summaryViewCount":8,"startDateTime":null,"durationSecs":326,"endDateTime":null,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":0,"associations":["RACGP"],"rewards":["Reviewing Performance • 0.5 hours"],"rewardImages":[{"image":"5d64f0d6ae84ff1cde65cfd2894173e396aba166d91def6443888242","aspectRatio":2.396}],"presenters":[{"id":18322,"specialty":{"id":94,"name":"General Practice"},"name":"Sneha Wadhwani","title":null,"profileImage":"7695ec0028b2766d11eaa01c092d62cef40ff704b6f24372ee5096c0","profileImageThumbnail":"c651de82a2712a508a452b847afe2f8cb3c8a4cd5a04f7d0ab395d7d"}],"relatedEducation":[{"id":1447,"name":"Low ferritin, normal haemoglobin ","image":"f892f5d709d4c9795da1d4c0d98a5fef5844d98d80c3817ed61f2a0f","imageThumbnail":"7197b75ed4e9220df548f073c675338b74d608ede3f5e9601a27d03c","type":"video","startDateTime":null,"durationSecs":375,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1445,"name":"Adherence, monitoring and treatment failure","image":"42c6101fc6b109852056a409e1fed6c3f0822709743a40eb83dfd3c2","imageThumbnail":"9a2595f379105483f145c46085707f6720a1d5d0551ede0bb34f94f9","type":"video","startDateTime":null,"durationSecs":352,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1441,"name":"What does the McKay study show about oral iron formulation?","image":"81ca5de7c17d1dd41185a9696714ed678ed88cbfd01d72244c358c5f","imageThumbnail":"798f8bbaef4634a9c69c2a37693664f2eecf4d103c7c76e5d5069569","type":"video","startDateTime":null,"durationSecs":247,"associationEducationTypes":[],"organisation":{"id":101,"name":"Arrotex"}},{"id":1405,"name":"Hormonal Acne Management for General Practice","image":"c6507a6d4a2eaa2b0fbec06d1572d229893ec9fbf6aabb7afa540d8f","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"video","startDateTime":null,"durationSecs":5735,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1396,"name":"Acne in Gender-Affirming Care","image":"5cfdbc6378b39637620ca942ec44b9501852d3e94d156d2b1a2fb47f","imageThumbnail":"f7bf04fa60267c97cf09221a427e1d9577f2c49f4f19b6ea16dffc2e","type":"video","startDateTime":null,"durationSecs":398,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1388,"name":"The GP's role in second line therapy for Endometriosis","image":"d14cda1b05a5e3f26aba936158372444bfb03ee082bc1034f58a2d3c","imageThumbnail":"b80c45f17a4a4bf9271030173e8e84d94d8cd800849649bc987c1444","type":"video","startDateTime":null,"durationSecs":727,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}